Neuroendocrine Differentiation in Hormone Refractory Prostate Cancer Following Androgen Deprivation Therapy

European Urology

Volumn 45, Issue 5, 2004, Pages 586-592

  Hirano, Daisaku ^a   Okada, Yasuhiro ^a   Minei, Sadatsugu ^a   Takimoto, Yukie ^a   Nemoto, Norimichi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Androgen deprivation therapy; Hormone refractory; Neuroendocrine differentiation; Prostate cancer

Indexed keywords

ANTIANDROGEN; CHROMOGRANIN A; DEXAMETHASONE; ESTRAMUSTINE PHOSPHATE; FOSFESTROL; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; AUTOPSY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KRUSKAL WALLIS TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RISK ASSESSMENT; SCORING SYSTEM; STAINING; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROSTATIC NEOPLASMS;

EID: 1842788109     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2003.11.032     Document Type: Article

References (0)